Thermo Fisher Scientific (TMO) has approved a new $5 billion share repurchase authorization. This new program will replace the previous buyback authorization, which had approximately $1 billion remaining. The announcement indicates a continued commitment to returning capital to shareholders.
Original sourceTHERMO FISHER SCIENTIFIC INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$694.76
+2.63%
Alpha Vantage · 11/6/2026
One-year price history
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
+6.6%
3 months
+15.9%
6 months
+49.7%
1 year
+23.2%
Year to date
+20.2%
52-week range
$437.59 – $709.18
Fundamental snapshot
Latest reported period: Sep 26, 2026
Market cap
$257.42B
P/E
36.4
P/B
4.7
P/S
5.4
Revenue
$47.35B
Net income
$7.07B
Diluted EPS
18.96
Gross margin
41.10%
Net margin
14.90%
Return on equity
13.30%
Total debt
$41.37B
Cash
$5.46B
Free cash flow
$7.64B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 26, 2026 | $12.14B | $1.72B | 42.30% | 14.20% | $2.11B |
| Jun 27, 2026 | $11.99B | $1.74B | 40.70% | 14.50% | $1.68B |
| Mar 28, 2026 | $11.01B | $1.65B | 40.30% | 15.00% | $825M |
| Dec 31, 2025 | $12.22B | $1.96B | 41.00% | 16.10% | $3.02B |
| Sep 27, 2025 | $11.12B | $1.62B | 41.20% | 14.50% | $1.84B |
| Jun 28, 2025 | $10.86B | $1.62B | 40.60% | 14.90% | $1.11B |
| Mar 29, 2025 | $10.36B | $1.51B | 40.90% | 14.50% | $373M |
| Dec 31, 2024 | $11.4B | $1.83B | 42.30% | 16.10% | $2.83B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent TMO news
All market newsLisa P. Britt, an officer at Thermo Fisher Scientific Inc. (TMO), has proposed selling 2,831 common shares with an aggregate market value of nearly $2 million. The sale is scheduled for approximately October 28, 2026, through Fidelity Brokerage Services LLC on the NYSE. Britt had previously sold a significant number of shares in August 2026, totaling over $10 million.
Original source